Trial Profile
A Real-World Analysis Evaluating Characteristics And Outcomes of Patients With Type 2 Diabetes Mellitus Treated With Canagliflozin Using A Large Health Plan Database (Optum Research Database: 6 Month Follow Up Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 May 2016 New trial record
- 16 May 2016 Results published in the Media Release